Upcoming Conferences in the Life Sciences Industry

East/West CEO

11 Jan 20 - 12 Jan 20
Four Seasons Hotel
San Francisco USA

East/West CEO: For CEOs about the run the gauntlet of the JP Morgan Healthcare Conference, prepare your game plan and leverage the experience of your peers at this invitation-only, off-the-record event taking place January 11-12, 2020 in San Francisco. This meeting will convene senior-level executives to discuss the most pressing issues facing the industry. Keynote speakers include Chris Gibson, Founder & CEO of Recursion Pharmaceuticals, Marianne De Backer, EVP Global Head of BD & Licensing of Bayer Pharmaceuticals, Brian Wallach, Co-founder of I AM ALS, and many more.

Contact:
Participation:
Venture Valuation / Biotechgate will participate in East/West CEO.
Contact us to schedule a meeting ››

Biotech Showcase

13 Jan 20 - 15 Jan 20
Hilton San Francisco Union Square
San Francisco USA

Biotech Showcase™ is the investor conference that drives the future of drug development. Showcase your company to life science investors and strategic partners during the industry’s most important annual gathering.

Contact:
Participation:
Venture Valuation / Biotechgate will participate in Biotech Showcase.
Contact us to schedule a meeting ››

38th Annual J.P. Morgan Healthcare Conference

13 Jan 20 - 16 Jan 20
Westin St. Francis Hotel
San Francisco USA

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

Participation:
Venture Valuation / Biotechgate will participate in 38th Annual J.P. Morgan Healthcare Conference.
Contact us to schedule a meeting ››

RESI San Francisco

14 Jan 20 - 14 Jan 20
Marines’ Memorial Club & Hotel
San Francisco USA

RESI San Francisco has become the key venue to meet early stage investors and companies during the annual January healthcare conference week. Millions upon millions of dollars have been invested in early stage companies following a connection at RESI SF. In January 2019, RESI SF’s partnering system was booked to capacity, with early stage companies and investors – 1200 attendees in total – connecting all day both in scheduled and ad hoc meetings. LSN will be launching the 2020 RESI calendar with RESI SF on January 14th at the Marine’s Memorial Club and Hotel.

Contact:
Participation:
Venture Valuation / Biotechgate will participate in RESI San Francisco.
Contact us to schedule a meeting ››

Global Forum for Food and Agriculture (GFFA)

16 Jan 20 - 18 Jan 20

Berlin Germany

The Global Forum for Food and Agriculture (GFFA) is an international conference on agri-food policy issues. Over three days at the GFFA, approx. 2,000 international visitors from politics, industry, science and civil society discuss a key topic. In addition, the world’s largest informal Conference of Agriculture Ministers takes place on the third conference day as the highlight of the GFFA. Approximately 70 ministers of agriculture from around the world and high-level representatives of international organisations adopt a joint political communiqué on the respective key topic. The GFFA is held in Berlin in parallel with the International Green Week.

Contact:
Participation:
Venture Valuation / Biotechgate will participate in Global Forum for Food and Agriculture (GFFA).
Contact us to schedule a meeting ››

R&D Data Intel Leaders Forum

27 Jan 20 - 29 Jan 20
Hyperion Hotel
Basel Switzerland

Achieving excellence with R&D data will enable the life sciences industry to increase the speed and quality of innovation and is thus a major source of competitive advantage. Whether researchers and informaticians deal with “big data,” “deep data” or just put their data to smarter use, it is clear that the future of R&D is dependent on both smart technologies and clever researchers. The rapid progress of innovation in software and powerful hardware now allows human researchers to interpret masses of raw data in unique ways and is redefining the R&D business model. The benefits range from discovery and “omics” research, through to clinical trials and to real patients in the real-world. However, it is major technical, financial, and operational challenge is to turn “messy” data into structured data, that can be used for advanced analytics that can spot opportunities and achieve true insights. Some of the most promising areas of technological innovation making rapid progress include, for example, artificial intelligence, machine learning, cloud computing and the blockchain (distributed ledgers). There is also huge potential for efficient collaborations between the life science industry, technology companies, academic researchers, health systems, physicians, and health insurers to remove data silos. A deeper convergence between key stakeholders and advanced technologies will facilitate the discovery and development of powerful therapies, devices and advanced diagnostics to benefit patients. The “R&D Data Intel Leaders Forum” is the must attend event for those senior decision-makers, researchers, data scientists and technologists, looking to make the shift towards an integrated R&D and data strategy and for those looking to improve their implementation of data-driven approaches to enhance R&D specific decision-making and intelligence.

Contact:
Participation:
Venture Valuation / Biotechgate will participate in R&D Data Intel Leaders Forum.
Contact us to schedule a meeting ››

AgeingFIT

28 Jan 20 - 29 Jan 20

Nice France

AgeingFit is the first European event dedicated to innovation in the Healthy Ageing sector. The next edition of AgeingFit will be held on January 28th and 29th, 2020, in Nice (France) and will gather over 600 international attendees from more than 20 countries. For its 4th edition, AgeingFit will gather healthy ageing companies, service providers, accommodation and care facilities, private and public research institutes, specialized associations and clusters, investors, health insurance providers, legislators and institutions… Their goal? Fostering business, research and financial partnerships with the objective to launch innovative products and services to the senior market.

Contact:
Ms. Marine Pentier
Email: mpentier@eurasante.com

Swiss Nordic Bio 2020

06 Feb 20 - 06 Feb 20
Radison Airport Hotel
Zürich Switzerland

WHAT IS SWISS NORDIC BIO?

Swiss Nordic Bio is an investor and partnering conference connecting leading Nordic and Swiss healthcare companies with European investors. For more information about the event please visit www.swissnordicbio.com or contact us.


WHAT IS NEW 2020?

Swiss Nordic Bio 2020 = Publicly listed + Private. With Vator Securities, Swiss Nordic Bio will transform to the leading small & midcap healthcare conference and include the best publicly listed small & midcap healthcare companies, alongside exciting new start-ups in the field.


WHY ATTEND?

  • Meet the most promising healthcare companies from the Nordics & Switzerland
  • Exclusive conference, maximum 200 participants admitted
  • Efficient, 1 day event with ~400 1-on-1 meetings in one afternoon
  • 30+ listed company presentations & private company pitches

WHO SHOULD ATTEND?

  • Public equity investors focusing on SME’s
  • Family offices
  • Venture capital
  • Pharma & medtech innovation scouts
  • Leading listed healthcare companies
  • Cutting edge private healthcare companies



TIME AND PLACE?

Thursday, 6 February 2020, 08:00 – 18:00 @ Radisson Hotel Airport, Zurich, Switzerland



Contact:
Mr. Johan Almgren
Email: johan.almgren@business-sweden.se
Participation:
Venture Valuation / Biotechgate will participate in Swiss Nordic Bio 2020.
Contact us to schedule a meeting ››

BIO CEO & Investor Conference

10 Feb 20 - 11 Feb 20
New York Marriott Marquis
New York USA

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. In support of industry-wide success, the conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

Contact:
Email: info@bio.org
Participation:
Venture Valuation / Biotechgate will participate in BIO CEO & Investor Conference.
Contact us to schedule a meeting ››

Freeze-Drying Technology Summit

13 Feb 20 - 14 Feb 20

Austria Vienna

We are pleased to invite you to the Freeze-Drying Technology Summit, scheduled for February 13th and 14th 2020, in Vienna, Austria. This event provides the appropriate platform for industry leaders to discuss process innovation and technical aspects in lyophilization for the pharmaceutical industry, as well as food and cosmetics manufacturers, regulatory agencies, and academia. The summit will be focused on practical considerations for freeze-dried formulation development, process optimization, validation, and control. We will discuss the advancing concepts and regulatory considerations for lyophilized biologics, vaccines, expedition and emergency food, new-wave of cosmetic ingredients, and highly potent products. We are looking forward to your participation in this engaging Summit in Vienna this coming February!

Contact:

European HealthTech CEO Forum

18 Feb 20 - 18 Feb 20

Zurich Switzerland

Following the success of the HealthTech Investment Forum in Basel, we are happy to announce the European HealthTech CEO Forum, which will take place on the 18th of February at Hilton Zurich Airport Hotel, just a day before our European Life Sciences CEO Forum. We anticipate over 200 delegates, covering innovation in the digital health and medtech and devices sectors, with the target audience being corporate and financial investors/partners and advisors. The programme will feature topical keynotes and panels with industry leaders and over 20 corporate presentations by public, private and growth companies, and 20+ pitches by seed companies. Networking is supported by the online One-2-One meeting system which allows for pre-arranged meetings at the dedicated meeting facilities.

Contact:

13th Annual European Life Sciences CEO Forum

19 Feb 20 - 20 Feb 20

Zurich Switzerland

Back for its 13th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2020 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors. The forum also features keynote speeches by KOL, about 60 selected corporate presentations from established (public and private) and emerging biotech's seeking to promote investment and partnering opportunities, and 20+ pitches by seed companies and during our Rising Stars session. We expect over 350 delegates to attend the event. The forum will provide a number of networking opportunities via our online one-to-one meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities. We anticipate more than 1700 face-to-face meetings to take place throughout 2 days.

Contact:

Liquid Biopsy 2020

20 Feb 20 - 21 Feb 20

Lisbon Portugal

The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

Contact:

Pharma & Biotech Patent Litigation

25 Feb 20 - 26 Feb 20

Amsterdam Netherlands

Attend the largest annual gathering of leading in-house IP counsel, patent prosecutors and litigators, judges, and IP policy experts from around the globe, C5’s 12th Pharma & Biotech Patent Litigation. Get the knowledge and skills you need to address post-filing patent litigation challenges, and optimise your patent litigation strategy to continuously deliver efficient patent protection. Get 10% off your registration with this exclusive code: D10-630-630CX03

Contact:

BIO Asia International Conference

10 Mar 20 - 11 Mar 20
Grand Hyatt
Tokyo Japan

The BIO Asia International Conference in Tokyo brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market and throughout the region. Companies with more than 460 therapeutic assets from more than 25 countries pursued Partnering discussions at the 2019 Tokyo conference.

Participation:
Venture Valuation / Biotechgate will participate in BIO Asia International Conference.
Contact us to schedule a meeting ››

Europe CEO

22 Mar 20 - 22 Mar 20
Hotel Mercure Paris Porte de Versailles Expo
Paris France

Europe CEO is an invitation-only, off-the-record forum that brings together past, present and future leaders to network and share insights on challenges and opportunities impacting the international biopharma industry.

Contact:
Participation:
Venture Valuation / Biotechgate will participate in Europe CEO.
Contact us to schedule a meeting ››

BIO-Europe Spring

23 Mar 20 - 25 Mar 20
Porte de Versailles, Hall 7
Paris France

With a focus on European innovation and global collaboration, BIO-Europe Spring is the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in the most innovative biopharma clusters in Europe.

Contact:
Participation:
Venture Valuation / Biotechgate will participate in BIO-Europe Spring.
Contact us to schedule a meeting ››

The Pharma Business Development Course

26 Mar 20 - 27 Mar 20

Zurich Switzerland

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Contact:
Mr. Annelies Swaan
Email: annelies.swaan@celforpharma.com

Phar-East 2020

31 Mar 20 - 01 Apr 20
Resorts World Convention Centre
Singapore Singapore

Join us at Asia’s Pharma & Biotech Festival! The 3rd edition of Phar-East is happening in Singapore from 31 March to 1 April 2020. The conference will feature 5 premium theatres focusing on immunotherapy, regulatory affairs, Pharma 4.0, market access, biotech investments, clinical trials and an all-new track – Bio Data. If you want to be part of Asia’s fastest growing pharmaceutical and biotech market, you need to join us this 31 March – 1 April at Resorts World Sentosa

Contact:
Mr. Jonathan Mottram
Email: jonathan.mottram@terrapinn.com
Participation:
Venture Valuation / Biotechgate will participate in Phar-East 2020.
Contact us to schedule a meeting ››

Pharma-Biotech Product & Company Valuation

20 Apr 20 - 20 Apr 20

Basel Switzerland

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Contact:
Mr. Annelies Swaan
Email: annelies.swaan@celforpharma.com
Participation:
Venture Valuation / Biotechgate will participate in Pharma-Biotech Product & Company Valuation.
Contact us to schedule a meeting ››

Swiss Biotech Day

21 Apr 20 - 21 Apr 20
Congress Center Basel
Basel Switzerland

The Swiss Biotech Day is the leading biotechnology conference in Switzerland. It is not just the place to be for members of the Swiss Biotech Association, who traditionally meet there for the association’s Annual General Assembly, but also for entrepreneurs, investors, researchers, analysts, political decision makers and industry stakeholders from across Europe. What you can expect: · 900 attendees from 25 countries · Presentation of the Swiss Biotech Report · Swiss Biotech Success Stories · 50 exhibitors · Parallel tracks in the afternoon focused on innovative biotech start-ups and medium-sized biotech company presentations · Thematically focused panel discussions in the afternoon · Pre-scheduled one-to-one partnering meetings

Contact:
Participation:
Venture Valuation / Biotechgate will participate in Swiss Biotech Day.
Contact us to schedule a meeting ››

BioFuture

27 Apr 20 - 29 Apr 20

New York City USA

BioFuture -The Disruptive Age of Healthcare and Technology is organized by Demy-Colton, a producer of highly specialized targeted investor and business conferences exclusively for the biopharmaceutical and life sciences industry. The event will feature company presentations, plenary sessions and workshop, and will facilitate one-2-one meetings supported by the HelloPartnering platform.

Contact:
Mr. Lawrence Joseph
Email: ljoseph@demy-colton.com
Participation:
Venture Valuation / Biotechgate will participate in BioFuture.
Contact us to schedule a meeting ››

BioTrinity 2020

28 Apr 20 - 29 Apr 20
etc.venues
London United Kingdom

BioTrinity is a highly regarded two day conference that takes place in Central London from 28-29 April. The core mission of BioTrinity is to inspire growth and create opportunities for all who attend, which includes a mix of early-stage and emerging biotech, medtech and digital health companies, big pharma executives and life science investors.

Contact:
Ms. Emma Durham
Email: emma.durham@obn.org.uk
Participation:
Venture Valuation / Biotechgate will participate in BioTrinity 2020.
Contact us to schedule a meeting ››

Biologics: Quality Developments & Manufacturing Summit

14 May 20 - 15 May 20



Affiliated With The 4th Annual Antibody Drug Conjugates Summit We are pleased to invite you to the Biologics: Quality Developments & Manufacturing Summit, scheduled for May 14-15, 2020. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on the delivery of cost and quality efficient process development and manufacturing of biologics, including novel modalities. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in May!

Contact:

Boston CEO

18 May 20 - 19 May 20
Mandarin Oriental Hotel
Boston USA

Boston CEO is an invitation-only, off-the-record forum that brings together the past, present and future leaders in the biopharma community to network and share insights into the industry's challenges and opportunities

Contact:
Participation:
Venture Valuation / Biotechgate will participate in Boston CEO.
Contact us to schedule a meeting ››

BIO International Convention

08 Jun 20 - 11 Jun 20
San Diego Convention Center
San Diego USA

The BIO International Convention is the world's largest global biotechnology partnering event. From an enhanced partnering experience, to expanded registration benefits, insightful sessions, and unforgettable networking opportunities, BIO 2020 helps you dream big and tackle daunting industry challenges.

Contact:
Email: info@bio.org
Participation:
Venture Valuation / Biotechgate will participate in BIO International Convention.
Contact us to schedule a meeting ››

The Pharma Business Development Course

09 Jun 20 - 10 Jun 20

Brussels Belgium

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Contact:
Mrs. Annelies Swaan
Email: annelies.swaan@celforpharma.com

MedFIT

30 Jun 20 - 01 Jul 20

Grenoble France

Held on the 30th of June and 1st of July 2020 in Grenoble – France, and gathering 750 international participants from over 25 countries, MedFIT is the leading European business convention dedicated to innovation partnerships in the fields of medical technology, diagnostic and digital health. MedFIT is your opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to build partnerships for all public and private actors, to source innovative and competitive early-stage R&D projects, to facilitate the emergence of collaborative projects, to increase licensing opportunities, to obtain funding and to facilitate market access.

Contact:
Ms. Stéphanie Gautreau
Email: sgautreau@eurasante.com

The Pharma Business Development Course

29 Sep 20 - 30 Sep 20

Brussels Belgium

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Contact:
Mrs. Annelies Swaan
Email: annelies.swaan@celforpharma.com

BIO Investor Forum

20 Oct 20 - 23 Oct 20
Westin St. Francis Hotel
San Francisco USA

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.

Contact:
Email: info@bio.org
Participation:
Venture Valuation / Biotechgate will participate in BIO Investor Forum.
Contact us to schedule a meeting ››

Pharma-Biotech Product & Company Valuation

02 Dec 20 - 02 Dec 20

London United Kingdom

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Contact:
Mr. Annelies Swaan
Email: annelies.swaan@celforpharma.com
Participation:
Venture Valuation / Biotechgate will participate in Pharma-Biotech Product & Company Valuation.
Contact us to schedule a meeting ››

The Pharma Business Development Course

15 Dec 20 - 16 Dec 20

London United Kingdom

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Contact:
Mrs. Annelies Swaan
Email: annelies.swaan@celforpharma.com